Peter Tsao

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis

Jeffrey D. Greenberg, Joel M. Kremer, Jeffrey R. Curtis et al. · Annals of the Rheumatic Diseases · 2010 · 349 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Disease Activity in Rheumatoid Arthritis and the Risk of Cardiovascular Events

Daniel H. Solomon, George Reed, Joel M. Kremer et al. · Arthritis & Rheumatology · 2015 · 323 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity

Daniel H. Solomon, Joel M. Kremer, Jeffrey R. Curtis et al. · Annals of the Rheumatic Diseases · 2010 · 297 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14

Derivation and Internal Validation of an Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis: A Consortium of Rheumatology Researchers of North America Registry Study

Daniel H. Solomon, Jeffrey D. Greenberg, Jeffrey R. Curtis et al. · Arthritis & Rheumatology · 2015 · 166 citations

Medicine, Clinical Sciences, Internal Medicine +17

Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs

Daniel H. Solomon, Joel M. Kremer, Mark Fisher et al. · Seminars in Arthritis and Rheumatism · 2013 · 117 citations

Medicine, Pharmacology, Pharmacotherapy +10